Skip to main content
. 2022 Jun 11;15:17562848221100946. doi: 10.1177/17562848221100946

Figure 3.

Figure 3.

Proportion of patients who discontinued linaclotide use, by subgroups of interest.

IBS, irritable bowel syndrome; IBS-C, IBS predominantly with constipation.